253 related articles for article (PubMed ID: 37587767)
1. Artificial intelligence for dementia drug discovery and trials optimization.
Doherty T; Yao Z; Khleifat AAL; Tantiangco H; Tamburin S; Albertyn C; Thakur L; Llewellyn DJ; Oxtoby NP; Lourida I; ; Ranson JM; Duce JA
Alzheimers Dement; 2023 Dec; 19(12):5922-5933. PubMed ID: 37587767
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the potential of machine learning and artificial intelligence for dementia research.
Ranson JM; Bucholc M; Lyall D; Newby D; Winchester L; Oxtoby NP; Veldsman M; Rittman T; Marzi S; Skene N; Al Khleifat A; Foote IF; Orgeta V; Kormilitzin A; Lourida I; Llewellyn DJ
Brain Inform; 2023 Feb; 10(1):6. PubMed ID: 36829050
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
6. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
7. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X; Zhao Y; Qi Z; Hou S; Chen J
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
[TBL] [Abstract][Full Text] [Related]
9. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
Gupta RR
Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease.
Cheng F; Wang F; Tang J; Zhou Y; Fu Z; Zhang P; Haines JL; Leverenz JB; Gan L; Hu J; Rosen-Zvi M; Pieper AA; Cummings J
Cell Rep Med; 2024 Feb; 5(2):101379. PubMed ID: 38382465
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
12. Clinical Trials and Machine Learning: Regulatory Approach Review.
Dri DA; Massella M; Gramaglia D; Marianecci C; Petraglia S
Rev Recent Clin Trials; 2021; 16(4):341-350. PubMed ID: 34269668
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
Winchester LM; Harshfield EL; Shi L; Badhwar A; Khleifat AA; Clarke N; Dehsarvi A; Lengyel I; Lourida I; Madan CR; Marzi SJ; Proitsi P; Rajkumar AP; Rittman T; Silajdžić E; Tamburin S; Ranson JM; Llewellyn DJ
Alzheimers Dement; 2023 Dec; 19(12):5860-5871. PubMed ID: 37654029
[TBL] [Abstract][Full Text] [Related]
14. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges in application of artificial intelligence in pharmacology.
Kumar M; Nguyen TPN; Kaur J; Singh TG; Soni D; Singh R; Kumar P
Pharmacol Rep; 2023 Feb; 75(1):3-18. PubMed ID: 36624355
[TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
[TBL] [Abstract][Full Text] [Related]
17. Big Data and Artificial Intelligence Modeling for Drug Discovery.
Zhu H
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
[TBL] [Abstract][Full Text] [Related]
18. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
Tripathi N; Goshisht MK; Sahu SK; Arora C
Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
[TBL] [Abstract][Full Text] [Related]
19. Can computers conceive the complexity of cancer to cure it? Using artificial intelligence technology in cancer modelling and drug discovery.
Adams RC; Rashidieh B
Math Biosci Eng; 2020 Sep; 17(6):6515-6530. PubMed ID: 33378864
[TBL] [Abstract][Full Text] [Related]
20. Enhancing preclinical drug discovery with artificial intelligence.
Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
